409 related articles for article (PubMed ID: 22747752)
1. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
Schunter M; Chu H; Hayes TL; McConnell D; Crawford SS; Luciw PA; Bengmark S; Asmuth DM; Brown J; Bevins CL; Shacklett BL; Critchfield JW
BMC Complement Altern Med; 2012 Jun; 12():84. PubMed ID: 22747752
[TBL] [Abstract][Full Text] [Related]
2. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
Front Immunol; 2021; 12():688886. PubMed ID: 34135912
[TBL] [Abstract][Full Text] [Related]
3. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial.
González-Hernández LA; Jave-Suarez LF; Fafutis-Morris M; Montes-Salcedo KE; Valle-Gutierrez LG; Campos-Loza AE; Enciso-Gómez LF; Andrade-Villanueva JF
Nutr J; 2012 Oct; 11():90. PubMed ID: 23101545
[TBL] [Abstract][Full Text] [Related]
4. Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
Blázquez-Bondia C; Parera M; Català-Moll F; Casadellà M; Elizalde-Torrent A; Aguiló M; Espadaler-Mazo J; Santos JR; Paredes R; Noguera-Julian M
Front Immunol; 2022; 13():1066036. PubMed ID: 36569851
[TBL] [Abstract][Full Text] [Related]
5. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.
Cunningham-Rundles S; Ahrné S; Johann-Liang R; Abuav R; Dunn-Navarra AM; Grassey C; Bengmark S; Cervia JS
Nutrients; 2011 Dec; 3(12):1042-70. PubMed ID: 22292110
[TBL] [Abstract][Full Text] [Related]
6. The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.
Chevalier MF; Petitjean G; Dunyach-Rémy C; Didier C; Girard PM; Manea ME; Campa P; Meyer L; Rouzioux C; Lavigne JP; Barré-Sinoussi F; Scott-Algara D; Weiss L
PLoS Pathog; 2013; 9(6):e1003453. PubMed ID: 23818854
[TBL] [Abstract][Full Text] [Related]
7. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion.
Gascon RL; Narváez AB; Zhang R; Kahn JO; Hecht FM; Herndier BG; McGrath MS
J Acquir Immune Defic Syndr; 2002 Jun; 30(2):146-53. PubMed ID: 12045676
[TBL] [Abstract][Full Text] [Related]
8. Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study.
Valiathan R; Miguez MJ; Patel B; Arheart KL; Asthana D
PLoS One; 2014; 9(5):e97698. PubMed ID: 24842313
[TBL] [Abstract][Full Text] [Related]
9. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.
Kim CJ; Walmsley SL; Raboud JM; Kovacs C; Coburn B; Rousseau R; Reinhard R; Rosenes R; Kaul R
HIV Clin Trials; 2016 Jul; 17(4):147-57. PubMed ID: 27267710
[TBL] [Abstract][Full Text] [Related]
10. Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.
Eller MA; Blom KG; Gonzalez VD; Eller LA; Naluyima P; Laeyendecker O; Quinn TC; Kiwanuka N; Serwadda D; Sewankambo NK; Tasseneetrithep B; Wawer MJ; Gray RH; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
PLoS One; 2011 Apr; 6(4):e18779. PubMed ID: 21526194
[TBL] [Abstract][Full Text] [Related]
11. HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment.
Rueda CM; Velilla PA; Chougnet CA; Montoya CJ; Rugeles MT
PLoS One; 2012; 7(1):e30307. PubMed ID: 22276176
[TBL] [Abstract][Full Text] [Related]
12. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
Sereti I; Estes JD; Thompson WL; Morcock DR; Fischl MA; Croughs T; Beq S; Lafaye de Micheaux S; Yao MD; Ober A; Wilson EM; Natarajan V; Imamichi H; Boulassel MR; Lederman MM; Routy JP
PLoS Pathog; 2014 Jan; 10(1):e1003890. PubMed ID: 24497828
[TBL] [Abstract][Full Text] [Related]
13. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
14. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation.
Ellis CL; Ma ZM; Mann SK; Li CS; Wu J; Knight TH; Yotter T; Hayes TL; Maniar AH; Troia-Cancio PV; Overman HA; Torok NJ; Albanese A; Rutledge JC; Miller CJ; Pollard RB; Asmuth DM
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):363-70. PubMed ID: 21436711
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markers.
Bonato M; Galli L; Passeri L; Longo V; Pavei G; Bossolasco S; Bertocchi C; Cernuschi M; Balconi G; Merati G; Lazzarin A; La Torre A; Cinque P
BMC Infect Dis; 2017 Jan; 17(1):61. PubMed ID: 28077069
[TBL] [Abstract][Full Text] [Related]
17. Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection.
Page EE; Greathead L; Metcalf R; Clark SA; Hart M; Fuchs D; Pantelidis P; Gotch F; Pozniak A; Nelson M; Boasso A; Gazzard B; Kelleher P
J Acquir Immune Defic Syndr; 2014 Nov; 67(3):227-35. PubMed ID: 25314246
[TBL] [Abstract][Full Text] [Related]
18. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.
Serrano-Villar S; Vázquez-Castellanos JF; Vallejo A; Latorre A; Sainz T; Ferrando-Martínez S; Rojo D; Martínez-Botas J; Del Romero J; Madrid N; Leal M; Mosele JI; Motilva MJ; Barbas C; Ferrer M; Moya A; Moreno S; Gosalbes MJ; Estrada V
Mucosal Immunol; 2017 Sep; 10(5):1279-1293. PubMed ID: 28000678
[TBL] [Abstract][Full Text] [Related]
19. Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
Macatangay BJ; Yang M; Sun X; Morton J; De Gruttola V; Little S; Hogan C; Rinaldo CR;
J Acquir Immune Defic Syndr; 2017 May; 75(1):137-141. PubMed ID: 28198712
[TBL] [Abstract][Full Text] [Related]
20. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
